丁咯地尔治疗后循环缺血性眩晕的疗效观察

目的考察丁略地尔治疗后循环缺血性眩晕的疗效。方法将120名后循环缺血性眩晕病例随机分为治疗组（60例）和对照组（60例）。治疗组给予丁略地尔注射液150mg，对照组给予舒血宁注射液10m1，两组均静脉滴注，1次／日，14天为1疗程。监测患者血液流变学和后循环血流动力学指标。并行美国国立卫生院卒中量表（NIHSS）评分。结果治疗组眩晕症状改善迅速快，有效率93．33％，明显高于对照组（80％）。而且治疗组NIHSS评分，后循环血流速度、搏动指数以及患者全血高切、低切还原黏度，血浆黏度指标的改善均优于对照组。结论丁咯地尔能快速、有效地治疗后循环缺血性眩晕。

Efficacy of buflomedil on posterior circulation ischemic vertigo

Objective To evaluate the efficacy of buflomedil on posterior circulation ischemic vertigo. Methods Patients with posterior circulation ischemic vertigo were randomly divided into experiment group （n = 60） and control group （n=60）. The experiment group was treated with buflomedil and the control group was treated with Shuxuening. The oral effective rate, the onset time, the health stroke scale （NIHSS） score, the blood rheology and hemodynamics parameters were observed. Results Total effective rates in control and experiment group were 93.33% and 80%, respectively（P〈0.05）. The NIHSS score, blood flow velocity of posterior circulation, pulsatility index （PD, blood reduction viscosity of high and low shear rates and plasma viscosity were improved significantly in experimental group compared with control group. Conclusion It is effective to treat posterior circulation ischemic vertigo with buflomedil.